Frank Lee

Frank Lee

Chief Executive OfficeratPacira BioSciences· In proxies 2023–2024

Pay in FY2024Pacira BioSciences stock -44.2% the same year

Frank Lee was paid $15.9M in FY2024 (Dec). Pacira BioSciences stock fell 44.2% that year.

Pay$100 in the stock at the end of FY23 → $56
Pay is from the Summary Compensation Table of each Pacira BioSciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Pacira BioSciencesPublic company · 3 yr
    • Chief Executive Officer2023 – Present · 3 yrStock in role -6%
  2. PTC TherapeuticsPublic company · 4 yr
    • Director2022 – Present · 4 yrNo stock prices for these years
  3. Bolt Biotherapeutics, Inc. (Nasdaq: BOLT)Public company
    • Director? – PresentNo stock prices for these years
  4. Therini Bio, Inc.Public company · 1 yr
    • Director2023 – 2024 · 1 yrNo stock prices for these years
  5. Catamaran Bio, Inc.Public company · 2 yr
    • Director2022 – 2024 · 2 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?